Global  

Johnson & Johnson

U.S. multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

Johnson & Johnson    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Johnson & Johnson: U.S. multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies.

0
shares
ShareTweetSavePostSend
 

J&J, AstraZeneca resuming trials of vaccines [Video]

J&J, AstraZeneca resuming trials of vaccines

AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on..

Credit: Reuters Studio     Duration: 01:08Published
Global COVID-19 cases rise by a one-day record [Video]

Global COVID-19 cases rise by a one-day record

Global coronavirus cases rose by more than 400,000 for the first time late on Friday, a record one-day increase as much of Europe enacts new restrictions to curb the outbreak. Freddie Joyner has more.

Credit: Reuters - Politics     Duration: 01:18Published
Johnson & Johnson Halts COVID-19 Vaccine Trial Due to Unexplained Illness [Video]

Johnson & Johnson Halts COVID-19 Vaccine Trial Due to Unexplained Illness

Johnson & Johnson has paused the advanced clinical trial of its experimental COVID-19 vaccine after one of their 60,000 participants became ill.

Credit: Cover Video STUDIO     Duration: 01:19Published
Eli Lilly pauses trial of antibody drug over safety concern [Video]

Eli Lilly pauses trial of antibody drug over safety concern

Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President Donald Trump has been paused because of a safety..

Credit: Reuters - Politics     Duration: 01:12Published
J&J pauses COVID-19 vaccine trials due to illness [Video]

J&J pauses COVID-19 vaccine trials due to illness

Johnson & Johnson said on Monday it had temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, delaying one of the highest profile..

Credit: Reuters Studio     Duration: 01:19Published
EJ Espresso: J&J halts Covid drug trial; Bollywood takes on news channels [Video]

EJ Espresso: J&J halts Covid drug trial; Bollywood takes on news channels

Johnson & Johnson halts Covid drug trial as volunteer falls ill. Punjab to reopen schools for classes 9-12 from Oct 15. Delhi is breathing its most polluted air since Feb. And Bollywood takes on news..

Credit: HT Digital Content     Duration: 04:14Published
आखिर कब मिलेगी अच्छी खबर? Johnson & Johnson ने रोका कोरोना व [Video]

आखिर कब मिलेगी अच्छी खबर? Johnson & Johnson ने रोका कोरोना व

दुनियाभर में कोविड-19 महामारी के कहर के बीच कोरोना वायरस की वैक्सीन बनाने की..

Credit: HT Digital Content     Duration: 02:20Published
Johnson & Johnson's COVID-19 Vaccine Enters Phase 3 US Trials [Video]

Johnson & Johnson's COVID-19 Vaccine Enters Phase 3 US Trials

The drugmaker made the announcement on Wednesday, joining the ranks of Pfizer and Moderna who have been in Phase 3 trials since July.

Credit: Cover Video STUDIO     Duration: 01:22Published
EJ Espresso: UK will infect volunteers with Covid to test vaccine [Video]

EJ Espresso: UK will infect volunteers with Covid to test vaccine

J&J kicks off final trial of single-shot Covid vaccine. UK will infect volunteers with Covid to test vaccine. Rape case against Anurag Kashyap on actor's complaint. And have you seen ex-Bihar DGP's..

Credit: HT Digital Content     Duration: 07:15Published
J&J launches final study of COVID-19 vaccine [Video]

J&J launches final study of COVID-19 vaccine

The drug giant said it would begin a stage three trial of a single-shot vaccine, which could prove easier to administer than rivals that require two inoculations. This report produced by Zachary..

Credit: Reuters - Politics     Duration: 01:09Published

You Might Like


AstraZeneca, Johnson & Johnson to resume COVID-19 vaccine trials

On Friday, both AstraZeneca and Johnson & Johnson announced their coronavirus vaccine trials are set to resume in the U.S. after hitting pause when volunteers became sick.
CBS News - Published

Eli Lilly and Johnson & Johnson have paused COVID-19 vaccine trials. Why experts say that's reassuring, not frightening.

Experts say the recent pause on COVID-19 vaccine and treatment trials aren't unusual, but rather show scientific safety processes are working.
USATODAY.com - Published

Coronavirus treatment trials halted over safety concerns

Eli Lilly has suspended tests on a coronavirus antibody treatment over a potential safety concern. This comes one day after Johnson & Johnson put its COVID-19 vaccine tests on hold after a trial..
CBS News - Published

Johnson & Johnson pauses COVID-19 vaccine trial due to unexplained illness

johnson & johnson pauses covid-19 vaccine trial due to unexplained illness
Illustration by Ana Kova Johnson & Johnson’s clinical trial of its COVID-19 vaccine was paused after a volunteer came down with an unexplained illness. The company did not disclose what the..
The Verge - Published Also reported by •CBS NewsUSATODAY.com

Coronavirus updates: COVID-19 surges as a third of US states set records for new cases; Johnson & Johnson pauses vaccine trial

The virus is surging in 41 states. Johnson & Johnson pauses vaccine trial. Colleges adjust spring plans. Latest COVID-19 news.
USATODAY.com - Published

Covid 19 coronavirus: Second vaccine trial paused over 'unexplained illness'

covid 19 coronavirus: second vaccine trial paused over 'unexplained illness'
A late-stage study of Johnson & Johnson's Covid-19 vaccine candidate has been paused while the company investigates whether a study participant's "unexplained illness" is related to the shot.The..
New Zealand Herald - Published

Johnson & Johnson begins final-stage testing on single-dose COVID-19 vaccine

johnson & johnson begins final-stage testing on single-dose covid-19 vaccine
Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. The study starting Wednesday will be one of the world’s largest..
WorldNews - Published Also reported by •CBS News

Johnson & Johnson faces $2 billion lawsuit over opioids

Governor Andrew Cuomo says the pharmaceutical giant downplayed the risks of addictive painkillers.
CBS News - Published

8/27: CBSN AM

Johnson & Johnson to pay $572M in landmark opioid trial; Families transformed by gun violence
CBS News - Published

Brazil approves final tests of J&J virus vaccine

brazil approves final tests of j&j virus vaccine
Brazilian health regulators said Tuesday they had approved Johnson & Johnson’s experimental vaccine against the new coronavirus for the final stage of clinical trials, the fourth vaccine to receive..
WorldNews - Published

Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine

In Boston and in the Netherlands, scientists are racing to build a vaccine against the virus strangling the world.
NYTimes.com - Published

Human trials begin in fortnight, J&J works to ramp up production of affordable Covid vaccine: Top scientist

Johnson & Johnson is preparing the ground for the entry of a vaccine against Covid-19 and is expanding its manufacturing capacity to supply more than one billion doses through 2021 in a not-for-profit..
IndiaTimes - Published

Fair & Lovely to lose 'Fair' from name, says Unilever

fair & lovely to lose 'fair' from name, says unilever
MUMBAI: Unilever will drop the word “fair” from its “Fair & Lovely” skin lightening products, it said on Thursday, in the latest makeover of a brand in response to a global backlash against..
WorldNews - Published

J&J loses bid to overturn baby powder verdict, but damages cut to $2.12 billion

j&j loses bid to overturn baby powder verdict, but damages cut to $2.12 billion
A Missouri appeals court on Tuesday rejected Johnson & Johnson’s bid to throw out a jury verdict in favour of women who blamed their ovarian cancer on its baby powder and other talc products, but..
WorldNews - Published

Women With Cancer Awarded Billions in Baby Powder Suit

An appellate court in Missouri upheld more than $2 billion in damages against Johnson & Johnson, saying the company knew there was asbestos in its baby powder.
NYTimes.com - Published

Johnson & Johnson in talks with governments on possible COVID-19 vaccine

Johnson & Johnson is in talks with multiple governments and global organizations as it seeks to develop a COVID-19 vaccine, it said on Thursday after Reuters reported that the U.S. company is in talks..
Reuters - Published

J&J moves up start of coronavirus vaccine human trials to July

Johnson & Johnson moved up the start of human clinical trials for its experimental vaccine against the highly contagious coronavirus by two months to the second half of July, as the drugmaker rushes to..
Reuters - Published

J&J to begin human trials of COVID-19 vaccine in second half of July

Johnson & Johnson said on Wednesday it would start human trials of its potential COVID-19 vaccine in the second half of July.
Reuters - Published

Exclusive: Europe to accelerate trials of gene-engineered COVID-19 vaccines - sources

European officials aim to speed up trials for coronavirus vaccines containing genetically modified organisms, two EU sources told Reuters, in a move that could help shots developed by companies like..
Reuters India - Published

Does baby powder cause cancer? Johnson & Johnson stops selling talc powder after years of scrutiny

Is baby powder really safe? The Food and Drug Administration is trying to answer that question about talc, which is similar in structure to asbestos.
USATODAY.com - Published

Johnson & Johnson to stop selling talc baby powder in U.S. and Canada

Johnson & Johnson on Tuesday announced it would stop selling its talc Baby Powder in the United States and Canada, saying demand had dropped in the wake of what it called "misinformation" about the..
Reuters - Published Also reported by •BBC NewsUSATODAY.com

Johnson & Johnson to End Talc-Based Baby Powder Sales in North America

The company has faced thousands of lawsuits from cancer patients who claim that its talc was contaminated with asbestos, a known carcinogen, and that the company knew of the risks.
NYTimes.com - Published

J&J sees medical devices business recovery at end of year after taking coronavirus hit

Johnson & Johnson on Tuesday said it expects its medical device business to begin recovering in the fourth quarter as elective medical procedures delayed by the coronavirus pandemic start to resume.
Reuters - Published

J&J sees recovery in coronavirus-hit medical devices unit at end of year

Johnson & Johnson on Tuesday said it expects its medical device business to begin recovering in the fourth quarter as elective medical procedures delayed by the coronavirus pandemic start to resume.
Reuters - Published

Wall Street jumps 2% on hopes of lockdown easing; JPMorgan kicks off earnings

Wall Street rose more than 2% on Tuesday on signs some economies would ease strict coronavirus-induced lockdowns, with investors also looking at quarterly earnings from JPMorgan and Johnson & Johnson..
Reuters - Published

J&J beats profit estimates but coronavirus fuels forecast cut

j&j beats profit estimates but coronavirus fuels forecast cut
Johnson & Johnson on Tuesday beat analysts' estimates for first-quarter profit on higher sales of its cancer drugs and consumer products including Tylenol, while cutting its full-year forecast due to..
WorldNews - Published Also reported by •Reuters

Wall Street gains as banks, J&J kick off earnings

U.S. stock markets opened more than 1% higher on Tuesday as the quarterly earnings season kicked off with JPMorgan and Johnson & Johnson giving a first glimpse of the coronavirus outbreak's impact on..
Reuters - Published

Johnson & Johnson beats profit estimates but cuts forecast on coronavirus uncertainty

Johnson & Johnson on Tuesday beat analysts' estimates for first-quarter profit on higher sales of its cancer drugs and consumer products including Tylenol, while slashing its full-year forecast due to..
Reuters - Published

J&J, Moderna sign deals with U.S. to produce huge quantity of possible coronavirus vaccines

The U.S. government has cut deals with Johnson & Johnson and Moderna Inc and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines..
Reuters - Published

Johnson & Johnson plans to start human trial of COVID-19 vaccine by Sept

The first batches of a COVID-19 vaccine could be available for emergency use authorisation in early 2021, the company said.
IndiaTimes - Published

J&J, U.S. government plan 1 billion doses of coronavirus vaccine

Johnson & Johnson said on Monday that it and the U.S. government will invest $1 billion to create enough manufacturing capacity to make more than 1 billion doses of a vaccine it is testing to stop the..
Reuters - Published

J&J to start human testing of coronavirus vaccine by September

Johnson & Johnson plans to start human testing of its experimental coronavirus vaccine by September and make it ready for emergency use in early 2021, the drugmaker said on Monday.
Reuters - Published

Johnson & Johnson ramps up Tylenol production as demand surges

Johnson & Johnson is seeing a spike in demand for its Tylenol over-the-counter pain killer and other self-care products, the company said on Friday, as the global spread of the coronavirus prompts..
Reuters - Published

Closely watched opioid trial in New York postponed due to coronavirus

A highly anticipated trial pitting New York state against McKesson Corp, Johnson & Johnson, CVS Health Corp and others for allegedly fueling the opioid epidemic has been postponed due to the..
Reuters - Published

Judge orders Johnson & Johnson to issue graphic warnings on pelvic mesh products

The new warnings should be in place by March 20, the Federal Court said on Friday. Johnson & Johnson may seek further time in which to comply.
The Age - Published

Johnson & Johnson to pay out $2.6m over vaginal mesh implants

The Federal Court has ordered US pharmaceutical giant Johnson & Johnson to pay $2.6 million in damages to three Australian women who received faulty pelvic mesh implants.
SBS - Published



 Page 1  〉